Your partner for 800+ high-quality medicines.

All across the United States, people lean on us to deliver high-quality medicines that put better health within reach every day. We develop, manufacture and distribute a broad range of injectable, oral, nasal and inhalable generic and branded pharmaceutical products, including essential medicines that hospitals, physicians and pharmacists need to treat their patients.

US hospitals and Hikma

How our partners have leaned on us.

Hikma continues to play a major role in helping US hospitals and healthcare systems alleviate shortages of essential medicines.

Contract manufacturing offerings

How our partners have leaned on us.

A detailed look at how Hikma has brought its global manufacturing prowess to Columbus, Ohio, US and to its sterile injectable sites in Europe and in the US.

Seasonal allergy relief is here

How allergists lean on us.
Allergists can lean on Hikma to help treat millions of people in the US suffering from seasonal allergies.

Solving shortages

How our partners have leaned on us.
Hospitals partner with Hikma 503B for the essential compounded sterile injectable medicines they need.

Our injectable medicines

As one of the largest manufacturers by volume of sterile injectable medicines in the US, we serve the growing needs of thousands of hospitals and millions of patients, including through our Hikma 503B compounded sterile injectable products for hospitals.

Discover more

Oral, respiratory and other generic

We supply oral, respiratory and other generic and specialty products to the North American retail market, leveraging our state-of-the-art manufacturing facility in Columbus, Ohio.

Oral Nasal Generics
Discover more

Our specialty products

Our highly experienced pharmaceutical team develops, creates, manufactures and markets branded generics and in-licensed products across the US, and our portfolio continues to diversify.

Visit Hikma Speciality

Our CMO capabilities for oral, respiratory and other generic

Discover our world-class 360° pharmaceutical contract manufacturing (CMO) capabilities across a broad range of oral, respiratory and other generic dosage forms, best-in-class production facilities, and excellent quality track record.

Hikma 503B

We provide compounded sterile injectables for the US. We have a proven track record of cGMP in sterile drug manufacturing. We have extensive access to raw materials and established relationships with our hospital customers and we are FDA approved.

Discover more about 503B
Decorative image.
Decorative image.
Decorative image.
Decorative image.
Decorative image.
Hikma US highlights
2 R&D hubs
2,165 Employees
4 Manufacturing plants

Useful links

Last reviewed: July 1, 2025

Hikma has determined that the annual aggregate limit on covered promotional expenditures is set at $1,500.00 per covered Medical or Healthcare Professional.

This annual aggregate limit is based on an estimate of the maximum value of hospitality, promotional materials, and other items of value as defined herein that a Medical or Healthcare Professional may receive in a year.

The US site

The information provided in this site is intended for US audiences only. Always consult a healthcare professional for medical advice. Hikma is not responsible for any access to materials which are not intended for US audiences.